Skip to main content
. 2011 Jul-Aug;18(4):230–234. doi: 10.1155/2011/510874

Figure 2).

Figure 2)

Survey questions 6 and 7. A “When patients on oral monotherapy are transitioned to prostacyclin therapy do you routinely continue or discontinue the oral agent?” (n=26). B “When patients on oral combination therapy are transitioned to prostacyclin therapy do you routinely continue or discontinue both oral agents?” (n=26)